Rhinitis and Ospamox


Rhinitis Symptoms and Causes

Each spring, summer, and fall, trees, weeds, and grasses release tiny pollen grains into the air. Some of the pollen ends up in your nose and throat. This can trigger a type of allergy called hay fever.

Symptoms can include

  • Sneezing, often with a runny or clogged nose
  • Coughing and postnasal drip
  • Itching eyes, nose and throat
  • Red and watery eyes
  • Dark circles under the eyes

Your health care provider may diagnose hay fever based on a physical exam and your symptoms. Sometimes skin or blood tests are used. Taking medicines and using nasal sprays can relieve symptoms. You can also rinse out your nose, but be sure to use distilled or sterilized water with saline. Allergy shots can help make you less sensitive to pollen and provide long-term relief.

NIH: National Institute of Allergy and Infectious Diseases

Check out the latest treatments for rhinitis

rhinitis treatment research studies

Ospamox clinical trials, surveys and public health registries

Find Drug Side Effect reports

Ospamox Side Effects

Headache (14)
Pruritus (13)
Dyspnoea (9)
Abdominal Pain (6)
Hyperhidrosis (5)
Diarrhoea Haemorrhagic (4)
Cough (4)
Chest Pain (4)
Hypersensitivity (3)
Local Swelling (3)
Suffocation Feeling (2)
Dysphagia (2)
Enanthema (1)
Epileptic Aura (1)
Erythema (1)
Tongue Oedema (1)
Fatigue (1)
Lip Oedema (1)
Lip Swelling (1)
Rash (1)
Stupor (1)
Purulent Discharge (1)
Petechiae (1)
Rash Pustular (1)
Choking Sensation (1)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

11 year age chaild first dose

Does ospamox aggrivate hemroids? :-[

Good evening Dr. I would like to consult you on the use of antibiotic Sbamox without consulting a doctor and that because I suffer from inflammation of the anus What do you think to use to dry the wound

My child 20 month old got Ospamox to treat sore throat. After taking it for a few days she started to loose control overone of her legs. Her foot moved into a position as is is seen withthe physically disabled, turned in, and she

No exp

Skin rash, throat sore...itching

if montolucast suits pt how long can be given for allergic rhinitis and can it be repeated in next season

Have been taking Avamys for 11 days now. I have perennial allergic rhinitis. Ihad an ear syringed 2 days ago. It was completely blocked with wax. I am allergic to tree pollen, rye grass, house dust and mould. I have had several sinus infect

I am a chronic rhinitis sufferer with a 40 yeaar history of ear trouble, etc. Gromets have sorted out the ears to some extent. Lately I have had bronchitis and cant shake the cough - dripping sinus - cough cycle. The bronchitis was treated by prescr

I decided to treat it from the root and found out that a disfunctional adrenal gland or thyroid may cause the allergic reaction (allergic rhinitis and sinusitis). Docotors usually prescribe steroids and /or anti-histamines.. but really what they shou

I have been taking Pariet for over 6 months & just realised I must be suffering side effects...reoccuring Flu symptoms & Rhinitis, occasional leg cramps & awakening with visual disturbances.

I have recently been diagnosed with cirrhosis of the liver - should I stop taking Beconase for my Rhinitis?

It was precribed to me by my doctor and cautioned me to use it <b>LESS THAN 4 DAYS </b> else I will have a chronic rhinitis... Chronic means lifetime nasal congestion... so I always control myself to use it once in a while...

Triggers rhinitis migrain :'(

Rhinitis Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
Conditions: Allergic Rhinitis;   Non-allergic Rhinitis;   Chronic Urticaria
Outcome Measures: The recalcitrant symptoms of chronic Rhinitis or chronic urticaria;   The correlation between symptom severity and quality of life
2 Recruiting Controlled Trial of Chinese Herbal Medicine to Treat Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: Cure-Allergic Rhinitis Syrup;   Drug: Yu-ping-fung San;   Drug: Placebo
Outcome Measures: Rhino-conjunctivitis Questionnaire (symptom severity);   Rhino-conjunctivitis Quality of Life Questionnaire;   Constitution in Chinese Medicine Questionnaire
3 Recruiting Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
Conditions: Rhinitis, Allergic, Perennial;   Rhinitis, Allergic, Nonseasonal
Interventions: Biological: MK-8237 tablets;   Biological: Placebo tablets;   Drug: Rescue Medication: Self-Injectable Epinephrine;   Drug: Rescue Medication: Loratadine tablets;   Drug: Rescue Medication: Olopatadine ophthalmic drops;   Drug: Rescue Medication: Mometasone furoate nasal spray
Outcome Measures: Average Total Combined Rhinitis Score (TCRS);   Number of Participants Who Experience At Least One Adverse Event;   Number of Participants Who Discontinue Study Drug Due to an Adverse Event;   Average Rhinitis Daily Symptom Score (Rhinitis DSS);   Average Total Combined Rhinoconjunctivitis Score (TCS);   Average Rhinitis Daily Medication Score (Rhinitis DMS);   Average Allergic Rhinitis/Rhinoconjunctivitis Symptoms Assessed by Visual Analogue Scale (VAS)
4 Recruiting Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Intervention: Device: acupressure pellets
Outcome Measures: Rhinoconjunctivitis and Rhinitis Quality of Life questionnaire;   Psychological Measures
5 Recruiting The Effect of Exercises on Physiological Changes and Clinical Symptoms in Allergic Rhinitis Patients
Condition: Allergic Rhinitis
Interventions: Other: Aerobic exercise with Vit. C;   Other: Aerobic exercise;   Other: No exercise
Outcome Measures: Changes from baseline in Rhinitis symptoms;   Changes from baseline in cytokine;   Changes from baseline in pulmonary function;   Changes from baseline in cardiorespiratory fitness (VO2max);   Changes from baseline in nasal blood flow;   Changes from baseline in peak nasal inspiratory flow
6 Recruiting Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis
Conditions: Asthma;   Rhinitis
Intervention: Other: regular treatment
Outcome Measure: Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis
7 Recruiting NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: Oxymetazoline;   Other: Hydroxyl-propyl-methyl cellulose powder;   Other: Placebo (lactose powder)
Outcome Measures: Peak nasal inspiratory flow (PNIF) area under the curve (AUC) change between the placebo and active NoAl treatment on day 1;   Difference between the PNIF AUC D1-D8 differences between the two groups;   Differences in nasal mucociliary clearance (Saccharine test) between both groups.;   Visual analogue scale (VAS) for the separate Rhinitis symptoms between the two groups;   Change of each symptom score for congestion over 8 days;   Change of total Rhinitis symptom score (TRSS) over 8 days;   Difference in the applied rescue decongestant (total number of additional puffs of oxymetazoline or any other medications indicated for the treatment of allergic Rhinitis) as needed between the two groups;   Number and severity of adverse events
8 Recruiting A Study Evaluating the Effect of Inhaled and Nasal Corticosteroids on Short Term Growth in Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Conditions: Asthma;   Allergic Rhinitis
Interventions: Drug: Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo;   Drug: Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase;   Drug: QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo;   Drug: QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris;   Drug: Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase;   Drug: Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
Outcome Measures: The effect of Omnaris Nasal Spray & Alvesco Inhalation Aerosol vs Beconase AQ Nasal Spray & QVAR Inhalation Aerosol on short-term lower leg growth velocity as measured by knemometry in pediatric subjects w/ mild asthma & allergic Rhinitis.;   The Effects of Omnaris, Alvesco, Beconase AQ and QVAR vs Placebo Nasal Spray & Placebo Inhalation Aerosol on short-term lower leg growth velocity as measured by knemometry in pediatric subjects w/ mild asthma & allergic Rhinitis.
9 Recruiting Control and Burden of Asthma and Rhinitis
Conditions: Asthma;   Rhinitis
Intervention: Other: Diagnostic tests, medical interview and questionnaires
Outcome Measures: To validate the survey instruments used PAPS and PACS, with clinical and objective tests;   To compare the disease burden of the different groups of participants
10 Not yet recruiting Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Other: Grass pollen sublingual immunotherapy tablet;   Drug: Control
Outcome Measures: Change from Baseline in Ryegrass specific-IgG4 at 4 months and 12 months;   Change in Quality of Life assessed by an Allergic Rhinitis Quality of Life Questionnaire at 4, 8 and 12 months;   Change in Combined Symptoms and Medication requirements score at 4, 8 and 12 months;   Change in Fractional Exhaled Nitric Oxide at 4, 8, and 12 months;   Change in Helper and regulatory T cell response to ryegrass pollen at 4 months and 12 months;   Change in Ryegrass-specific IgE at 4 months and 12 months
11 Recruiting Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean
Conditions: Allergic Rhinitis;   Perennial Allergic Rhinitis;   Non-seasonal Allergic Rhinitis
Interventions: Drug: AGR tablet;   Drug: Placebo (for AGR tablet and/or Active Comparator);   Drug: Active Comparator
Outcome Measure: Change of 4NTSS(4 Nasal Total Symptoms score) from baseline
12 Recruiting Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids
Conditions: ASTHMA;   ALLERGIC Rhinitis
Interventions: Drug: Treatment with any inhaled corticosteroid;   Drug: Treatment with any intranasal glucocorticoid
Outcome Measure: Change in concentration of hair cortisol under topical corticosteroid treatment
13 Unknown  Preventing Tolerance to Oxymetazoline in Allergic Rhinitis
Conditions: Allergic Rhinitis;   Tachyphylaxis;   Rhinitis Medicamentosa
Interventions: Drug: oxymetazoline-fluticasone propionate;   Drug: Oxymetazoline
Outcome Measures: The primary endpoint will be the difference in peak PNIF response to incremental doses of Oxymetazoline [i.e. as a dose response];   Active Anterior Rhinomanometry;   Laser Doppler Velocimetry for nasal blood flow;   Overnight urinary cortisol creatinine ratio;   Nasal nitric oxide levels;   Serum eosinophils, ECP
14 Recruiting the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
Conditions: Perennial Allergic Rhinitis;   Probiotics;   Lactobacillus Paracasei GMNL-32 (eN-Lac®)
Interventions: Biological: eN-Lac®;   Other: Placebo
Outcome Measures: Evaluate the efficacy profile of probiotics Lactobacillus paracasei GMNL-32 (eN-Lac®) in children with perennial allergic Rhinitis.;   The safety features are evaluated through the changes of vital signs, physical examinations, laboratory test result (hematology, biochemistry and urinalysis tests), as well as the occurrence of adverse event.
15 Unknown  The Relationship Between Allergic Rhinitis and Geographic Tongue
Conditions: Allergic Rhinitis;   Geographic Tongue
Outcome Measure: Number of participants with Adverse Events
16 Recruiting Effect of Qi-tonifying Chinese Herbal Products for Treatment of Allergic Rhinitis
Condition: Allergic Rhinitis
Intervention: Drug: Qi-tonifying Chinese herbal products
Outcome Measures: Changes from Baseline in symptom severity at 3 months;   Change from Baseline in immunologic biomarkers at 3 months
17 Unknown  Montelukast and Nasal Epithelial Cell Inflammatory Responses in Asthma and Rhinitis
Conditions: Asthma;   Allergic Rhinitis
Outcome Measures: Effect of montelukast on nasal epithelial cell secretion in vitro.;   Effect of 1-week montelukast withdrawal on clinical scores and pro-inflammatory cytokine output by nasal epithelial cells
18 Recruiting Leukotriene D4 Nasal Provocation Test in Allergic Rhinitis
Conditions: Allergic Rhinitis;   Asthma
Interventions: Drug: leukotriene D4;   Drug: histamine
Outcome Measures: Percentage of participants positive response to leukotriene D4 or histamine nasal provocation test;   Change from baseline of eosinophils in sputum and nasal lavage and fractional exhaled nitric oxide (FeNO)
19 Unknown  CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic Rhinitis
Conditions: Asthma;   Allergic Rhinitis
Intervention: Procedure: Allergen challenge
Outcome Measures: Change in CysLT1-r following allergen challenge;   Change in CysLT1-r following low dose allergen challenge;   Difference in CysLT1-r expression in asthma and allergic Rhinitis
20 Not yet recruiting Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine
Condition: Allergic Rhinitis
Interventions: Drug: Esketamine;   Drug: Mometasone;   Drug: Oxymetazoline
Outcome Measures: Maximum Plasma Concentration (Cmax);   Time to Reach Maximum Concentration (tmax);   Area Under the Plasma Concentration-Time Curve From Time Zero to Infinite Time (AUC [0-infinity]);   Elimination Half-Life (t [1/2] Lambda);   Number of participants with adverse events (AEs) and serious adverse events (SAEs)